Russell Wilson

64 year

Health Technology

Consumer Services

Profile

Presently, Russell P. Wilson holds the position of Senior Vice President-Business Development for Novavax, Inc. He previously occupied the position of Chief Financial Officer & Vice President at Supernus Pharmaceuticals, Inc., Chief Financial Officer, Secretary & Senior VP at Intercell USA, Inc. and General Counsel at North American Vaccine, Inc. He received an MBA and a graduate degree from the University of Virginia and an undergraduate degree from Princeton University.

Former positions of Russell Wilson

Companies	Position	End
NOVAVAX, INC.	Chief Tech/Sci/R&D Officer	28/03/2012
IOMAI CORPORATION	Director of Finance/CFO	01/08/2008
North American Vaccine, Inc. North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million.	General Counsel	01/01/2000
SUPERNUS PHARMACEUTICALS, INC.	Director of Finance/CFO	-

See the detail of Russell Wilson's experience

Training of Russell Wilson

University of Virginia	Graduate Degree
Princeton University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Russell Wilson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
NOVAVAX, INC.	Health Technology
SUPERNUS PHARMACEUTICALS, INC.	Health Technology

Private companies	2
North American Vaccine, Inc. North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million.	Health Technology
Intercell USA, Inc. Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD.	Health Technology